The effect of the JAK inhibitor CP-690,550 on peripheral immune parameters in stable kidney allograft patients
Introduction.: CP-690,550 inhibits Janus kinase 3 (JAK3) which mediates signal transduction of receptors of the common γ-chain cytokines. These cytokines play key roles in lymphocyte function and homeostasis. As part of a phase 1 trial, we evaluated the effect of CP-690,550 on immune parameters. Material.: Stable kidney transplant recipients (n=8) receiving mycophenolate mofetil and prednisolone were treated with CP-690,550, 30 mg twice daily orally for 29 days. Blood samples were collected on days 1 (before first dose), 15, 29 (end of treatment), and 57. Results.: Two patients experienced minor infections (one urinary tract infection and one mild respiratory tract infection). Leukocyte counts remained stable, whereas a mean decrease in hemoglobulin of 8% was measured (P=0.01). CP-690,550 treatment for 29 days resulted in statistically significant changes in the number of circulating CD19 B cells (P=0.05), CD3CD16CD56 natural killer-cells (P<0.01), and CD4CD25 T cells (P=0.05; one-way analysis of variance). After CP-690,550 treatment on day 15 the number of B cells increased by a mean of 100%, (P=0.04), whereas those of natural killer cells and CD4CD25 T cells decreased by 65% (P=0.001) and 38% (P=0.03, t test), respectively, from pretreatment baseline. However, the regulatory capacities of the residual CD4CD25 T cells remained unchanged pre- and posttreatment. In addition, in the presence of CP-690,550, the interferon-γ production capacity of peripheral blood mononuclear cells was reduced by 39% (median) compared with predose baseline (P=0.01). Conclusions.: These findings demonstrate the role of JAK3 in the homeostasis and function of select lymphocyte subpopulations. JAK3 inhibition may provide a novel mechanism for the modulation of allogeneic responses in patients after transplantation.
|Keywords||Biomarkers, JAK3, Kidney transplant patients, New immunosuppression|
|Persistent URL||dx.doi.org/10.1097/TP.0b013e31818bbea7, hdl.handle.net/1765/25091|
van Gurp, E., Schoordijk-Verschoor, W., Klepper, M., Korevaar, S.S., Chan, G., Weimar, W., & Baan, C.C.. (2009). The effect of the JAK inhibitor CP-690,550 on peripheral immune parameters in stable kidney allograft patients. Transplantation, 87(1), 79–86. doi:10.1097/TP.0b013e31818bbea7